APO Research
Talk to an analyst

APO RESEARCH · REPORT

Low Molecular Weight Heparin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Low Molecular Weight Heparin Injection Industry Research Report 2026

27 December 2025125 pages

Choose your research edition.

Industry ResearchLow Molecular Weight Heparin Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Low Molecular Weight Heparin Injection Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Low Molecular Weight Heparin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Low Molecular Weight Heparin Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Low Molecular Weight Heparin Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Low Molecular Weight Heparin Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Low Molecular Weight Heparin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Low Molecular Weight Heparin Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Low Molecular Weight Heparin Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Low Molecular Weight Heparin Injection include Tianjin Chasesun Pharmaceutical, Qilu Pharmaceutical, Kunming Jida Pharmaceutical, Jiangsu Wanbang Biopharmaceuticals, Hebei Changshan Biochemical Pharmaceutical, Hainan GT-Unipul Pharmaceutical, He'nan Xuchang Huaren Pharmaceutical, Sanofi and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Low Molecular Weight Heparin Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Low Molecular Weight Heparin Injection Market by Company

Tianjin Chasesun Pharmaceutical

Qilu Pharmaceutical

Kunming Jida Pharmaceutical

Jiangsu Wanbang Biopharmaceuticals

Hebei Changshan Biochemical Pharmaceutical

Hainan GT-Unipul Pharmaceutical

He'nan Xuchang Huaren Pharmaceutical

Sanofi

Pfizer

Opocrin

Aspen

Low Molecular Weight Heparin Injection Segment by Type

Low Molecular Weight Heparin Sodium Injection

Low Molecular Weight Heparin Calcium Injection

Low Molecular Weight Heparin Injection Segment by Application

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Others

Low Molecular Weight Heparin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Molecular Weight Heparin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Low Molecular Weight Heparin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Molecular Weight Heparin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Low Molecular Weight Heparin Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Low Molecular Weight Heparin Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Low Molecular Weight Heparin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Low Molecular Weight Heparin Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Low Molecular Weight Heparin Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Low Molecular Weight Heparin Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Low Molecular Weight Heparin Injection Revenue of Manufacturers (2021-2026) Table 9. Global Low Molecular Weight Heparin Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Low Molecular Weight Heparin Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Low Molecular Weight Heparin Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Low Molecular Weight Heparin Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Low Molecular Weight Heparin Injection, Product Type & Application Table 14. Global Low Molecular Weight Heparin Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Low Molecular Weight Heparin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Tianjin Chasesun Pharmaceutical Company Information Table 19. Tianjin Chasesun Pharmaceutical Business Overview Table 20. Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 22. Tianjin Chasesun Pharmaceutical Recent Developments Table 23. Qilu Pharmaceutical Company Information Table 24. Qilu Pharmaceutical Business Overview Table 25. Qilu Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Qilu Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 27. Qilu Pharmaceutical Recent Developments Table 28. Kunming Jida Pharmaceutical Company Information Table 29. Kunming Jida Pharmaceutical Business Overview Table 30. Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 32. Kunming Jida Pharmaceutical Recent Developments Table 33. Jiangsu Wanbang Biopharmaceuticals Company Information Table 34. Jiangsu Wanbang Biopharmaceuticals Business Overview Table 35. Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Product Portfolio Table 37. Jiangsu Wanbang Biopharmaceuticals Recent Developments Table 38. Hebei Changshan Biochemical Pharmaceutical Company Information Table 39. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 40. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 42. Hebei Changshan Biochemical Pharmaceutical Recent Developments Table 43. Hainan GT-Unipul Pharmaceutical Company Information Table 44. Hainan GT-Unipul Pharmaceutical Business Overview Table 45. Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 47. Hainan GT-Unipul Pharmaceutical Recent Developments Table 48. He'nan Xuchang Huaren Pharmaceutical Company Information Table 49. He'nan Xuchang Huaren Pharmaceutical Business Overview Table 50. He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio Table 52. He'nan Xuchang Huaren Pharmaceutical Recent Developments Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sanofi Low Molecular Weight Heparin Injection Product Portfolio Table 57. Sanofi Recent Developments Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Pfizer Low Molecular Weight Heparin Injection Product Portfolio Table 62. Pfizer Recent Developments Table 63. Opocrin Company Information Table 64. Opocrin Business Overview Table 65. Opocrin Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Opocrin Low Molecular Weight Heparin Injection Product Portfolio Table 67. Opocrin Recent Developments Table 68. Aspen Company Information Table 69. Aspen Business Overview Table 70. Aspen Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Aspen Low Molecular Weight Heparin Injection Product Portfolio Table 72. Aspen Recent Developments Table 73. Global Low Molecular Weight Heparin Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Low Molecular Weight Heparin Injection Sales by Region (2021-2026) & (K Units) Table 75. Global Low Molecular Weight Heparin Injection Sales Market Share by Region (2021-2026) Table 76. Global Low Molecular Weight Heparin Injection Sales by Region (2027-2032) & (K Units) Table 77. Global Low Molecular Weight Heparin Injection Sales Market Share by Region (2027-2032) Table 78. Global Low Molecular Weight Heparin Injection Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Low Molecular Weight Heparin Injection Revenue Market Share by Region (2021-2026) Table 80. Global Low Molecular Weight Heparin Injection Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Low Molecular Weight Heparin Injection Revenue Market Share by Region (2027-2032) Table 82. North America Low Molecular Weight Heparin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 84. North America Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 85. North America Low Molecular Weight Heparin Injection Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Low Molecular Weight Heparin Injection Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Low Molecular Weight Heparin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 89. Europe Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 90. Europe Low Molecular Weight Heparin Injection Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Low Molecular Weight Heparin Injection Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Low Molecular Weight Heparin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Low Molecular Weight Heparin Injection Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Low Molecular Weight Heparin Injection Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Low Molecular Weight Heparin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 99. South America Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 100. South America Low Molecular Weight Heparin Injection Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Low Molecular Weight Heparin Injection Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Low Molecular Weight Heparin Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Low Molecular Weight Heparin Injection Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Low Molecular Weight Heparin Injection Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Low Molecular Weight Heparin Injection Sales by Type (2021-2026) & (K Units) Table 108. Global Low Molecular Weight Heparin Injection Sales by Type (2027-2032) & (K Units) Table 109. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2021-2026) Table 110. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2027-2032) Table 111. Global Low Molecular Weight Heparin Injection Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Low Molecular Weight Heparin Injection Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2021-2026) Table 114. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2027-2032) Table 115. Global Low Molecular Weight Heparin Injection Price by Type (2021-2026) & (US$/Unit) Table 116. Global Low Molecular Weight Heparin Injection Price by Type (2027-2032) & (US$/Unit) Table 117. Global Low Molecular Weight Heparin Injection Sales by Application (2021-2026) & (K Units) Table 118. Global Low Molecular Weight Heparin Injection Sales by Application (2027-2032) & (K Units) Table 119. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2021-2026) Table 120. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2027-2032) Table 121. Global Low Molecular Weight Heparin Injection Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Low Molecular Weight Heparin Injection Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2021-2026) Table 124. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2027-2032) Table 125. Global Low Molecular Weight Heparin Injection Price by Application (2021-2026) & (US$/Unit) Table 126. Global Low Molecular Weight Heparin Injection Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Low Molecular Weight Heparin Injection Distributors List Table 130. Low Molecular Weight Heparin Injection Customers List Table 131. Low Molecular Weight Heparin Injection Industry Trends Table 132. Low Molecular Weight Heparin Injection Industry Drivers Table 133. Low Molecular Weight Heparin Injection Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Low Molecular Weight Heparin Injection Product Image Figure 5. Global Low Molecular Weight Heparin Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Low Molecular Weight Heparin Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Low Molecular Weight Heparin Injection Sales (2021-2032) & (K Units) Figure 8. Global Low Molecular Weight Heparin Injection Average Price (US$/Unit) & (2021-2032) Figure 9. Low Molecular Weight Heparin Sodium Injection Product Image Figure 10. Low Molecular Weight Heparin Calcium Injection Product Image Figure 11. Treatment of Venous Thromboembolism Product Image Figure 12. Complications of Pregnancy Product Image Figure 13. Cardioversion of Atrial Fibrillation/Flutter Product Image Figure 14. Others Product Image Figure 15. Global Low Molecular Weight Heparin Injection Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Low Molecular Weight Heparin Injection, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Low Molecular Weight Heparin Injection Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Low Molecular Weight Heparin Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Low Molecular Weight Heparin Injection Sales by Region in 2025 Figure 21. Global Low Molecular Weight Heparin Injection Revenue by Region in 2025 Figure 22. North America Low Molecular Weight Heparin Injection Market Size by Country in 2025 Figure 23. North America Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 24. North America Low Molecular Weight Heparin Injection Revenue Market Share by Country (2021-2032) Figure 25. United States Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Low Molecular Weight Heparin Injection Market Size by Country in 2025 Figure 29. Europe Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 30. Europe Low Molecular Weight Heparin Injection Revenue Market Share by Country (2021-2032) Figure 31. Germany Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Low Molecular Weight Heparin Injection Market Size by Country in 2025 Figure 42. Asia Pacific Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Low Molecular Weight Heparin Injection Revenue Market Share by Country (2021-2032) Figure 44. China Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Low Molecular Weight Heparin Injection Market Size by Country in 2025 Figure 53. South America Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 54. South America Low Molecular Weight Heparin Injection Revenue Market Share by Country (2021-2032) Figure 55. Brazil Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Low Molecular Weight Heparin Injection Market Size by Country in 2025 Figure 60. Middle East and Africa Low Molecular Weight Heparin Injection Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Low Molecular Weight Heparin Injection Revenue Market Share by Country (2021-2032) Figure 62. Egypt Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Low Molecular Weight Heparin Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2021-2032) Figure 68. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2021-2032) Figure 69. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Type (2021-2032) Figure 70. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2021-2032) Figure 71. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2021-2032) Figure 72. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Application (2021-2032) Figure 73. Low Molecular Weight Heparin Injection Value Chain Figure 74. Low Molecular Weight Heparin Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Low Molecular Weight Heparin Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • Low Molecular Weight Heparin Sodium Injection
  • Low Molecular Weight Heparin Calcium Injection
Applications
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Others
Companies covered
  • Tianjin Chasesun Pharmaceutical
  • Qilu Pharmaceutical
  • Kunming Jida Pharmaceutical
  • Jiangsu Wanbang Biopharmaceuticals
  • Hebei Changshan Biochemical Pharmaceutical
  • Hainan GT-Unipul Pharmaceutical
  • He'nan Xuchang Huaren Pharmaceutical
  • Sanofi
  • Pfizer
  • Opocrin
  • Aspen

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Low Molecular Weight Heparin Injection Market Size (2021-2032)
  4. 2.2.2 Global Low Molecular Weight Heparin Injection Sales (2021-2032)
  5. 2.2.3 Global Low Molecular Weight Heparin Injection Market Average Price (2021-2032)
  6. 2.3 Low Molecular Weight Heparin Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Low Molecular Weight Heparin Sodium Injection
  9. 2.3.3 Low Molecular Weight Heparin Calcium Injection
  10. 2.4 Low Molecular Weight Heparin Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Treatment of Venous Thromboembolism
  13. 2.4.3 Complications of Pregnancy
  14. 2.4.4 Cardioversion of Atrial Fibrillation/Flutter
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Low Molecular Weight Heparin Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Low Molecular Weight Heparin Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Low Molecular Weight Heparin Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Low Molecular Weight Heparin Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Low Molecular Weight Heparin Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Low Molecular Weight Heparin Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Low Molecular Weight Heparin Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Low Molecular Weight Heparin Injection, Established Date
  9. 3.9 Global Low Molecular Weight Heparin Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Tianjin Chasesun Pharmaceutical
  2. 4.1.1 Tianjin Chasesun Pharmaceutical Company Information
  3. 4.1.2 Tianjin Chasesun Pharmaceutical Business Overview
  4. 4.1.3 Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  6. 4.1.5 Tianjin Chasesun Pharmaceutical Recent Developments
  7. 4.2 Qilu Pharmaceutical
  8. 4.2.1 Qilu Pharmaceutical Company Information
  9. 4.2.2 Qilu Pharmaceutical Business Overview
  10. 4.2.3 Qilu Pharmaceutical Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Qilu Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  12. 4.2.5 Qilu Pharmaceutical Recent Developments
  13. 4.3 Kunming Jida Pharmaceutical
  14. 4.3.1 Kunming Jida Pharmaceutical Company Information
  15. 4.3.2 Kunming Jida Pharmaceutical Business Overview
  16. 4.3.3 Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  18. 4.3.5 Kunming Jida Pharmaceutical Recent Developments
  19. 4.4 Jiangsu Wanbang Biopharmaceuticals
  20. 4.4.1 Jiangsu Wanbang Biopharmaceuticals Company Information
  21. 4.4.2 Jiangsu Wanbang Biopharmaceuticals Business Overview
  22. 4.4.3 Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Product Portfolio
  24. 4.4.5 Jiangsu Wanbang Biopharmaceuticals Recent Developments
  25. 4.5 Hebei Changshan Biochemical Pharmaceutical
  26. 4.5.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  27. 4.5.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  28. 4.5.3 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  30. 4.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  31. 4.6 Hainan GT-Unipul Pharmaceutical
  32. 4.6.1 Hainan GT-Unipul Pharmaceutical Company Information
  33. 4.6.2 Hainan GT-Unipul Pharmaceutical Business Overview
  34. 4.6.3 Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  36. 4.6.5 Hainan GT-Unipul Pharmaceutical Recent Developments
  37. 4.7 He'nan Xuchang Huaren Pharmaceutical
  38. 4.7.1 He'nan Xuchang Huaren Pharmaceutical Company Information
  39. 4.7.2 He'nan Xuchang Huaren Pharmaceutical Business Overview
  40. 4.7.3 He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Product Portfolio
  42. 4.7.5 He'nan Xuchang Huaren Pharmaceutical Recent Developments
  43. 4.8 Sanofi
  44. 4.8.1 Sanofi Company Information
  45. 4.8.2 Sanofi Business Overview
  46. 4.8.3 Sanofi Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sanofi Low Molecular Weight Heparin Injection Product Portfolio
  48. 4.8.5 Sanofi Recent Developments
  49. 4.9 Pfizer
  50. 4.9.1 Pfizer Company Information
  51. 4.9.2 Pfizer Business Overview
  52. 4.9.3 Pfizer Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Pfizer Low Molecular Weight Heparin Injection Product Portfolio
  54. 4.9.5 Pfizer Recent Developments
  55. 4.10 Opocrin
  56. 4.10.1 Opocrin Company Information
  57. 4.10.2 Opocrin Business Overview
  58. 4.10.3 Opocrin Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Opocrin Low Molecular Weight Heparin Injection Product Portfolio
  60. 4.10.5 Opocrin Recent Developments
  61. 4.11 Aspen
  62. 4.11.1 Aspen Company Information
  63. 4.11.2 Aspen Business Overview
  64. 4.11.3 Aspen Low Molecular Weight Heparin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Aspen Low Molecular Weight Heparin Injection Product Portfolio
  66. 4.11.5 Aspen Recent Developments
5 Global Low Molecular Weight Heparin Injection Market Scenario by Region
  1. 5.1 Global Low Molecular Weight Heparin Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Low Molecular Weight Heparin Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Low Molecular Weight Heparin Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Low Molecular Weight Heparin Injection Sales by Region: 2027-2032
  5. 5.3 Global Low Molecular Weight Heparin Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Low Molecular Weight Heparin Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Low Molecular Weight Heparin Injection Revenue by Region: 2027-2032
  8. 5.4 North America Low Molecular Weight Heparin Injection Market Facts & Figures by Country
  9. 5.4.1 North America Low Molecular Weight Heparin Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Low Molecular Weight Heparin Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Low Molecular Weight Heparin Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Low Molecular Weight Heparin Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Low Molecular Weight Heparin Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Low Molecular Weight Heparin Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Low Molecular Weight Heparin Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Low Molecular Weight Heparin Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Low Molecular Weight Heparin Injection Market Facts & Figures by Country
  41. 5.7.1 South America Low Molecular Weight Heparin Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Low Molecular Weight Heparin Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Low Molecular Weight Heparin Injection Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Low Molecular Weight Heparin Injection Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Low Molecular Weight Heparin Injection Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Low Molecular Weight Heparin Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Low Molecular Weight Heparin Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Low Molecular Weight Heparin Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Low Molecular Weight Heparin Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Low Molecular Weight Heparin Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Low Molecular Weight Heparin Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Low Molecular Weight Heparin Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Low Molecular Weight Heparin Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Low Molecular Weight Heparin Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Low Molecular Weight Heparin Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Low Molecular Weight Heparin Injection Value Chain Analysis
  2. 8.1.1 Low Molecular Weight Heparin Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Low Molecular Weight Heparin Injection Production Mode & Process
  5. 8.2 Low Molecular Weight Heparin Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Low Molecular Weight Heparin Injection Distributors
  8. 8.2.3 Low Molecular Weight Heparin Injection Customers
9 Global Low Molecular Weight Heparin Injection Analyzing Market Dynamics
  1. 9.1 Low Molecular Weight Heparin Injection Industry Trends
  2. 9.2 Low Molecular Weight Heparin Injection Industry Drivers
  3. 9.3 Low Molecular Weight Heparin Injection Industry Opportunities and Challenges
  4. 9.4 Low Molecular Weight Heparin Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst